Bolton, MA and San Antonio, TX (PRWEB) May 19, 2016
Intrinsic Imaging, an FDA audited, ISO 9001, 13485 and 22301 certified medical imaging core lab specializing in providing services for Phase I-IV clinical trials, will be sponsoring a webinar on the virtues for study sponsors to rely on a Quality Management System that is backed by ISO certifications. The webinar is scheduled for May 24th at 2:00pm ET.
Join Todd Joron, President and COO at Intrinsic Imaging, for a discussion on the advantages of having a methodical process and an ISO 9001, ISO 13485 and ISO 22301 certified quality management system designed specifically for managing all aspects of imaging conducted during pharmaceutical and medical device clinical trials.
Case studies are also presented and examined.
- ISO 9001 in support of Phase I, II and III clinical trials in support of new drug applications
- ISO 13485 in support of Class I, II and III medical device clinical trials 510(k) and PMA
- ISO 22301 and ensuring business continuity of the entire medical imaging lifecycle in clinical trials
To sign up for this complimentary webinar please go to:
Registration URL: https://attendee.gotowebinar.com/register/3689902023092519425
Webinar ID: 102-161-283
Or go to http://www.intrinsiccro.com for additional information.
About Intrinsic Imaging
Located in Bolton, Massachusetts and San Antonio, Texas, Intrinsic Imaging is an FDA audited, ISO 9001, 13485 and 22301 certified, medical imaging core lab specializing in providing imaging core lab services for clinical trials. With its team of more than sixty-five board-certified fellowship trained radiologists, robust and scalable clinical imaging technologies and our ISO certified and registered quality management systems, Intrinsic Imaging is ideally positioned to provide unprecedented imaging core lab services around the world.
Craig Pennington, BSc.
Vice President, Marketing & Communications